NUR 555 Module 4 Comparison Paper Example

One Gland, Two Antibody Stories: Hashimoto Thyroiditis and Graves Disease Compared

[Student Name]

Southern New Hampshire University

NUR 555: Advanced Clinical Pathophysiology

Comparison Paper

[Instructor Name]

[Date]

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

One Gland, Two Antibody Stories: Hashimoto Thyroiditis and Graves Disease Compared

Hashimoto thyroiditis and Graves disease are both autoimmune diseases of the thyroid, both far more common in women and both marked by antibodies against thyroid proteins. Yet one leaves the patient hypothyroid and the other hyperthyroid. This paper argues that the difference lies in what the immune response does to the thyroid cell: in Hashimoto thyroiditis, lymphocytes and cytotoxic mechanisms destroy it, while in Graves disease an antibody binds the TSH receptor and drives it continuously, so the laboratory pattern, the examination and even the eyes follow from that single contrast.

Two Patients

Patient E, a 52-year-old woman who teaches middle school, has felt exhausted for six months, is always cold, has gained 4 kg, is constipated and has dry skin. The gland feels uniformly enlarged and rubbery without tenderness, and ankle reflexes relax slowly. Thyroid-stimulating hormone (TSH) is 14.2 mIU/L, free thyroxine (T4) is low and anti-thyroid peroxidase (anti-TPO) antibodies are strongly positive.

Patient F, a 31-year-old woman who works as a graphic designer, has lost 5 kg in two months despite eating more, feels her heart racing, cannot tolerate heat, has a fine tremor and says her eyes feel gritty and look bigger. Her pulse is 112, the whole gland is swollen and a soft bruit can be heard over it and her eyes protrude slightly with lid retraction. TSH is undetectable, free T4 is high and TSH receptor antibodies are positive.

Hashimoto Thyroiditis: Destruction

In Hashimoto thyroiditis, loss of tolerance to thyroid antigens leads to infiltration of the gland by T and B lymphocytes, sometimes forming germinal centers. Cytotoxic T cells and cytokine-mediated apoptosis destroy thyroid follicular cells over months to years, and antibodies to thyroid peroxidase and thyroglobulin appear in the blood (Ralli et al., 2020). The antibodies are excellent markers of the process, but the damage is driven mainly by cell-mediated mechanisms.

As follicles are lost, thyroid hormone production falls. The pituitary senses low hormone levels and raises TSH, which explains Patient E's high TSH with low free T4, the pattern of primary hypothyroidism. The gland may enlarge from lymphocytic infiltration and TSH stimulation, as hers has, before eventually shrinking. Low thyroid hormone slows metabolism and many tissues at once, producing fatigue, cold intolerance, weight gain, constipation, dry skin and slow reflex relaxation.

Graves Disease: Stimulation

In Graves disease, antibodies latch onto the follicular cell's TSH receptor and imitate the hormone, but without feedback control. They stimulate hormone production and growth of the gland continuously, so the thyroid enlarges diffusely, becomes highly vascular, which explains the bruit, and releases excess T4 and T3 (Smith & Hegedüs, 2016). The pituitary responds to high hormone levels by shutting off TSH, which is why Patient F's TSH is undetectable. This is an antibody-mediated process of an unusual kind: the antibody activates its target rather than destroying it, sometimes described as a stimulatory form of type II hypersensitivity.

Excess thyroid hormone raises metabolic rate and sensitizes tissues to adrenergic signals, producing weight loss despite a good appetite, heat intolerance, tachycardia, anxiety and tremor. The eyes are affected for a separate reason. Orbital fibroblasts also express the TSH receptor, and in Graves orbitopathy the immune response targets them, leading to inflammation, expansion of orbital fat and swelling of the eye muscles that push the eyes forward (Smith & Hegedüs, 2016).

Why Both Patients Feel It Everywhere

Thyroid hormone acts on nearly every cell, which is why both disorders produce symptoms far from the neck. Thyroid hormone enters cells and binds nuclear receptors that regulate genes for metabolism, heat production and the sensitivity of tissues to catecholamines (Rogers, 2023). Too little, as in Patient E, lowers the metabolic rate and heat production, slows gut motility and reflex relaxation and allows water-binding substances to accumulate in the skin. Too much, as in Patient F, raises the metabolic rate and heat production, speeds the heart and increases adrenergic sensitivity, which explains her tremor and racing pulse. The symptoms of the two diseases are therefore mirror images, and each can be read as a measure of how far hormone levels have moved in one direction.

The Two Diseases in One Table

The features that separate the two diseases are gathered in Table 1.

Table 1

Hashimoto Thyroiditis and Graves Disease Compared

What Decides Between Them

The single most useful test is TSH, because it points in opposite directions: high in Hashimoto thyroiditis, suppressed in Graves disease. Free T4 confirms the direction. Antibodies then identify the cause, anti-TPO for Hashimoto thyroiditis and TSH receptor antibodies for Graves disease, and the eye findings, when present, are almost specific for Graves. The picture is not always clean. Early Hashimoto thyroiditis can briefly release stored hormone and cause transient hyperthyroidism, and some patients carry both types of antibody, which is why the whole pattern, not one value, makes the diagnosis (Ralli et al., 2020).

How Mechanism Shapes Treatment

Because Hashimoto thyroiditis destroys the gland, treatment replaces what is lost: levothyroxine, adjusted to bring TSH into range. Because Graves disease overstimulates a working gland, treatment reduces production or removes tissue: antithyroid drugs such as methimazole block hormone synthesis, radioactive iodine destroys overactive tissue and surgery removes it, while a beta-blocker controls adrenergic symptoms in the meantime (Smith & Hegedüs, 2016). An irony connects the two: treating Graves disease with radioactive iodine or surgery often leaves the patient hypothyroid, needing the same levothyroxine as Patient E.

Conclusion

Hashimoto thyroiditis and Graves disease are two autoimmune responses to the same gland with opposite results. In Patient E, lymphocytes destroyed follicular cells, TSH rose and the body slowed. In Patient F, antibodies switched on the TSH receptor, TSH fell to nothing and the body sped up, while a related attack on orbital fibroblasts pushed the eyes forward. TSH decides the direction, antibodies identify the cause and the mechanism dictates whether treatment replaces hormone or reduces its production.

References

Ralli, M., Angeletti, D., Fiore, M., D'Aguanno, V., Lambiase, A., Artico, M., de Vincentiis, M., & Greco, A. (2020). Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmunity Reviews, 19(10), Article 102649. https://doi.org/10.1016/j.autrev.2020.102649

Rogers, J. L. (Ed.). (2023). McCance & Huether's pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier.

Smith, T. J., & Hegedüs, L. (2016). Graves' disease. New England Journal of Medicine, 375(16), 1552-1565. https://doi.org/10.1056/NEJMra1510030